Clik here to view.
AmpliPhi Biosciences Provides Update on Phase I Trial: Phage Therapy Well...
SAN DIEGO AmpliPhi Biosciences Corporation (NYSEMKT: APHB), a global leader in the development of bacteriophage-based antibacterial therapies to treat drug-resistant infections, today provided an...
View ArticleClik here to view.
Clik here to view.
Acucela to Present at ARVO 2016 Annual Meeting’s Education Courses in Seattle
SEATTLE Acucela Inc. (Tokyo: 4589) (“Acucela”), a clinical-stage ophthalmology company that specializes in identifying and developing novel therapeutics to treat and slow the progression of...
View ArticleClik here to view.
フランスの大学病院の1つがSpHb®、PVI®、SET®パルスオキシメトリーを搭載したマシモのRadical-7®を採用
スイス・ヌーシャテル （ビジネスワイヤ） — マシモ（NASDAQ:...
View ArticleClik here to view.
エボテックとエクセンシアがbispecific低分子腫瘍免疫薬の創薬での提携を発表
独ハンブルク & スコットランド・ダンディー (BUSINESS WIRE)– （ビジネスワイヤ） — エボテック（Frankfurt Stock Exchange: EVT、TecDAX、ISIN:...
View ArticleClik here to view.
PerkinElmer and Genome Institute of Singapore Open Joint Research Laboratory...
WALTHAM, Mass. & SINGAPORE PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, and the Genome Institute of Singapore (GIS), a biomedical...
View ArticleClik here to view.
Excelra Knowledge Solutions Extends License of Its Biomarker Database– GOBIOM...
HYDERABAD, India Excelra Knowledge Solutions today announced that it has extended its GOBIOM (Global Online Biomarker Database) license to the Biomarker Qualification Group of the USFDA. Excelra...
View ArticleClik here to view.
Dr. Reddy’s to Release Q4 and Full Year FY16 Results on May 12, 2016;...
HYDERABAD, India Dr. Reddy’s Laboratories (NYSE: RDY; NSE: DRREDDY; BSE: 500124) will announce results for the Fourth Quarter and Full Year ended March 31, 2016 on Thursday, May 12, 2016 after the...
View ArticleClik here to view.
PPD Expands Medical Communications Operations into Asia-Pacific Region
WILMINGTON, N.C. Pharmaceutical Product Development, LLC (PPD) has expanded its medical communications services into the Asia-Pacific region, enabling the contract research organization (CRO) to...
View ArticleClik here to view.
FDA Issues Complete Response Letter for Digital Medicine New Drug Application
TOKYO & REDWOOD CITY, Calif. Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Proteus Digital Health (Proteus) today announced that the United States Food and Drug Administration (FDA) has issued a...
View ArticleClik here to view.
Phase 3 Trial Results for First Oral Proteasome Inhibitor NINLARO (ixazomib)...
CAMBRIDGE, Mass. & OSAKA, Japan Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that results from the international, randomized, double-blind, placebo-controlled TOURMALINE-MM1...
View ArticleClik here to view.
《新英格兰医学杂志》发表首个口服蛋白酶体抑制剂NINLARO (ixazomib)的3期试验结果
马萨诸塞州剑桥和日本大阪 (美国商业资讯) –武田药品工业株式会社(TSE: 4502)今天宣布，国际性、随机、双盲、安慰剂对照、3期TOURMALINE-MM1临床研究的结果已发表在著名的《新英格兰医学杂志》(NEJM)上，该研究评估每周一次口服NINLARO®...
View ArticleClik here to view.
Agilent Technologies Presents Thought Leader Award to Renowned Medicinal...
SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE:A) today announced that Dr. Shilin Chen has received an Agilent Thought Leader Award in support of his groundbreaking herbal genomics research...
View ArticleClik here to view.
初の経口プロテアソーム阻害薬NINLARO（イキサゾミブ）の第3相試験結果がニューイングランド・ジャーナル・オブ・メディシンに掲載
米マサチューセッツ州ケンブリッジ & 大阪 （ビジネスワイヤ） — 武田薬品工業株式会社（TSE:...
View ArticleClik here to view.
Colorcon Announces New Film Coating Manufacturing Plant in Brazil
HARLEYSVILLE, Pa. Colorcon Inc. is pleased to announce its investment in a new film coating manufacturing plant in Indaiatuba – São Paulo State, Brazil, supporting the continued growth of the...
View ArticleClik here to view.
22nd Century Group采用其战略供应商Celanese Corporation的革命性新过滤嘴技术
纽约州克拉伦斯 (美国商业资讯) — 22nd Century Group, Inc. (NYSE MKT:XXII)是一家植物生物技术公司，主要使命是引领新技术、以减少吸烟所致的危害，该公司今天宣布，它已与Celanese Corporation签署一份供应安排。通过该安排，22nd...
View ArticleClik here to view.
Clik here to view.
Exelixis Announces First Quarter 2016 Financial Results and Provides...
SOUTH SAN FRANCISCO Exelixis, Inc. (Nasdaq: EXEL) today reported financial results for the first quarter of 2016 and provided an update on progress toward delivering upon its key 2016 corporate...
View ArticleClik here to view.
Gynesonics Names Jiayu Chen, Ph.D., Vice President, Engineering and Advanced...
REDWOOD CITY, Calif. Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced that medical device...
View ArticleClik here to view.
IMS Health将与昆泰合并 Quintiles IMS将成为行业领先的信息和技术驱动型医疗服务提供商
康涅狄格州丹伯里与北卡州三角研究园 (美国商业资讯)–IMS Health Holdings, Inc. (NYSE:IMS)与Quintiles Transnational Holdings Inc. (NYSE:Q): Smart News Releases（智能新闻稿）是一个多媒体平台。在此处查看完整新闻稿：...
View Article